Applications of Fluorine in Medicinal Chemistry
E.P. Gillis, K.J. Eastman, M.D. Hill, D.J. Donnelly, N.A. Meanwell.
J. Med. Chem., Article ASAP.
Organic Carbamates in Drug Design and Medicinal Chemistry
A.K. Ghosh, M. Brindisi.
J. Med. Chem., 2015, 58, 2895.
A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design
B.R. Beno, K. Yeung, M.D. Barberger, L.D. Pennington, N.A. Meanwell.
J. Med. Chem., 2015, 58, 4383.
CNS Drug Design: Balancing Physiochemical Properties for Optimal Brain Exposure
J. Med. Chem., 2015, 58, 2584
Additivity of Substitutent Effects in Aromatic Stacking Interactions
J. Hwang, P.Li, W.R. Carroll, M.D. Smith, P.J Pellechia, D.D. Shimizu.
J. Am. Chem. Soc., 2014, 136, 14060.
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Nicholas A. Meanwell
J. Med. Chem. 2011, 54, 2529.
Improving Drug Candidates by Design: A Focus on Physiochemical Properties as a Means of Improving Compound Disposition and Safety
Nicholas A. Meanwell.
Chem. Res. Toxicol. 2011, 24, 1420.
The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
S.D. Roughley, A.M.Jordan.
J. Med. Chem., 2011, 54, 3451.
A Medicinal Chemist’s Guide to Molecular Interactions
C. Bissantz, B.K. Kuhn, and M. Stahl.
J. Med. Chem., 2010, 53, 5061.
Biomolecular Ligand-Receptor Binding Studies: Theory, Practice, and Analysis
Charles R. Sanders.
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
J.B. Baell and G.A. Holloway
J. Med. Chem., 2010, 53, 2719.